• LAVA Moderator: Shinji Ikari

the market: stocks, bonds, options, whatever

Can't believe I didn't buy more in the .30's and .40's but bankruptcy was way more on the table then compared to now, so I can't really beat myself up I guess
 
TMF looks good to buy if they really do lower rates and keep lowering rates. TLT if you don't want 3x leverage

My theory is they're gonna lower rates and inflation will spike again, because the Fed Reserve isn't actually independant of the govt any longer and is clearly influenced by the govt, so the govt will inflate their way out of our massive national debt instead of just spending less. Everything will cost more but our debt to gdp ratio will be lower
 
What if nvidia has another huge move higher wednesday, making it the most valuable company ever. Buy the above etfs if they go down due to that happening?

GV376-TWEAA79bi
 
My long corporate bonds are doing great now, finally.

My new speculative investment is in prediction markets on Polymarket. I've made some good returns in a short period, but I've been betting on high-likelihood events, so one wrong bet would quickly erase everything I've gained (and more). It's a lot of fun!
 
So I know absolutely nothing about stocks, bonds, etc. Mom is 94 and has dementia. When she dies I will be inheriting some P&G shares (I have no idea how many, but not a lot), and I was wondering:
1. Is it worth much?
2. How do I go about selling?
3. Should I hold onto it as long as I can?
4. Mom has considerable credit card debt. Will creditors be able to seize those shares or the money from selling them?
 
So I know absolutely nothing about stocks, bonds, etc. Mom is 94 and has dementia. When she dies I will be inheriting some P&G shares (I have no idea how many, but not a lot), and I was wondering:
1. Is it worth much?
2. How do I go about selling?
3. Should I hold onto it as long as I can?
4. Mom has considerable credit card debt. Will creditors be able to seize those shares or the money from selling them?

 
$SGMO +48%

"Sangamo Therapeutics shares rose after the company said the outcome of a recent successful interaction with the Food and Drug Administration provided a clear regulatory pathway to accelerated approval of isaralgagene civaparvovec, or ST-920, for Fabry disease"

"
The Richmond, Calif., company said the FDA agreed in a Type B interaction that data from the ongoing phase 1/2 study of ST-920 can serve as the primary basis for approval under the accelerated approval program to treat the lysosomal disorder that results in excessive deposition of lipids in the tissues.

The complete dataset to support an accelerated approval pathway will be available in the first half of 2025, the company said.

Sangamo said this approach unlocks a potential biologics license application submission in the second half of 2025, three years ahead of previous estimates, and avoids the requirement for an additional registrational study to establish clinical efficacy"

 
$SGMO +33%. Would be a great time to announce a FABRY partnership since the trials will take 3 less years now
 
There aren't many stocks i can stand behind.
Big pharma is a no.
Gold and silver mining stock are a yes.
But I don't know which ones to get except for Franco Nevada.
I would've doubled my money on Hershey had I bought it when it was recommended to me in 2015.

My feelings on stocks is moreso that I'm seeking investors to get my distillery off the ground and start my own business.
 
Top